These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 5355888)

  • 21. Enforcement policy: recalls (including product corrections)--guidelines on policy, procedures, and industry responsibilities.
    Fed Regist; 1978 Jun; 43(117):26201-21. PubMed ID: 10316619
    [No Abstract]   [Full Text] [Related]  

  • 22. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 23. Assuring the quality of the nation's drugs. Interview by William E. Small.
    Michels D
    Am Pharm; 1980 Apr; NS20(4):40-2. PubMed ID: 7386377
    [No Abstract]   [Full Text] [Related]  

  • 24. World agencies try to stem flood of fake drugs.
    Surendran A
    Nat Med; 2004 Feb; 10(2):111. PubMed ID: 14760401
    [No Abstract]   [Full Text] [Related]  

  • 25. Who really assures prescription drug quality?
    J Indiana State Med Assoc; 1979 Mar; 72(3):164. PubMed ID: 422862
    [No Abstract]   [Full Text] [Related]  

  • 26. Reporting drug product defects--JCAHO.
    Hoffmann RP
    Hosp Pharm; 1989 Feb; 24(2):143-4. PubMed ID: 10318199
    [No Abstract]   [Full Text] [Related]  

  • 27. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 28. The regulation of biopharmaceuticals.
    Weisbroth N
    Qual Assur; 1993; 2(1-2):147-51. PubMed ID: 8156202
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. United States Food and Drug Administration's viewpoint.
    Ley HL; Desmond FH
    Can Med Assoc J; 1968 Feb; 98(6):318-21. PubMed ID: 5636100
    [No Abstract]   [Full Text] [Related]  

  • 30. Standardization of forensic drug analyses.
    Frank RS; Gunn JW
    J Forensic Sci; 1974 Jan; 19(1):163-7. PubMed ID: 4854386
    [No Abstract]   [Full Text] [Related]  

  • 31. The relationship between the pharmaceutical industry and government agencies.
    Johnston RV
    J Am Vet Med Assoc; 1965 Dec; 147(12):1588-92. PubMed ID: 5884057
    [No Abstract]   [Full Text] [Related]  

  • 32. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
    Marsh DA; Hoar ME
    Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory aspects of parenteral drugs.
    Jennings J
    Bull Parenter Drug Assoc; 1972; 26(2):53-7. PubMed ID: 5012204
    [No Abstract]   [Full Text] [Related]  

  • 34. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA
    Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug Product Problem Reporting Program.
    FDA Drug Bull; 1979 Aug; 9(3):18. PubMed ID: 467875
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharma's year of trouble and strife.
    Frantz S
    Nat Rev Drug Discov; 2006 Jan; 5(1):7-9. PubMed ID: 16485339
    [No Abstract]   [Full Text] [Related]  

  • 37. Institute of Medicine's new drug safety report: implications for Canada.
    Cassels A
    CMAJ; 2006 Dec; 175(12):1515-6. PubMed ID: 17146086
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug defect reporting program.
    Valentino JG
    Bull Parenter Drug Assoc; 1975; 29(2):55-63. PubMed ID: 1120213
    [No Abstract]   [Full Text] [Related]  

  • 39. Establishing the efficacy of psychotropic agents.
    Levine J; Schiele BC; Bouthilet L
    Psychopharmacol Bull; 1971 Jul; 7(3):16-22. PubMed ID: 5117845
    [No Abstract]   [Full Text] [Related]  

  • 40. [Standardization as a basis planning and administration in drug industry and pharmacy (II)].
    Wagler M
    Pharm Prax; 1970; 7():151-3. PubMed ID: 5469874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.